SCHEMBL7053659

SCHEMBL7053659

CCCc1cccc(OC(CCNC)c2ccccc2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 13/20 0.68
CACNA2D1 P54289 1/20 0.54
KMT2A Q03164 6/20 0.53
MEN1 O00255 5/20 0.53
LMNA P02545 5/20 0.53
CYP2D6 P10635 5/20 0.53
CYP3A4 P08684 5/20 0.53
CYP1A2 P05177 4/20 0.53
CYP2C19 P33261 3/20 0.53
SLC6A2 P23975 3/20 0.53
HTR2C P28335 3/20 0.53
SLC6A3 Q01959 3/20 0.53
TSHR P16473 3/20 0.53
NPC1 O15118 2/20 0.53
MTOR P42345 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 2/20 0.53
ALOX15 P16050 2/20 0.53
THPO P40225 2/20 0.53
CHRM1 P11229 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Decanoic Acid SCHEMBL5458412 0.88 SLC6A4 (0.54) SLC6A4CACNA2D1KMT2AMEN1CYP2D6
SCHEMBL5313499 0.84 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3KCNH2KCNK2
SCHEMBL5011928 0.82 SLC6A4 (1.00) SLC6A4KMT2AMEN1LMNACYP2D6
SCHEMBL8197696 0.82 SLC6A4 (1.00) SLC6A4KMT2AMEN1LMNACYP2D6
SCHEMBL5014117 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA
SCHEMBL31733949 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA
SCHEMBL30163449 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA
SCHEMBL1200769 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA
SCHEMBL1200912 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA
SCHEMBL7053900 0.81 SLC6A4 (0.75) SLC6A4CACNA2D1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0831799-B1 COMPOUNDS ACTIVE AT A NOVEL SITE ON RECEPTOR-OPERATED CALCIUM CHANNELS USEFUL FOR TREATMENT OF NEUROLOGICAL DISORDERS NPS PHARMA INC (US) 2003-05-02 EP claimed